1. Discovery and Characterization of R/S-N-3-Cyanophenyl-N′-(6-tert-butoxycarbonylamino-3,4-dihydro-2,2-dimethyl-2H-1-benzopyran-4-yl)urea, a New Histone Deacetylase Class III Inhibitor Exerting Antiproliferative Activity against Cancer Cell Lines
    Michael Schnekenburger et al, 2017, J. Med. Chem. CrossRef
  2. Regulation of HSF1 protein stabilization: an updated review
    Chao Huang et al, 2018, European Journal of Pharmacology CrossRef
  3. Asiatic acid suppresses neuroinflammation in BV2 microglia via modulation of the Sirt1/NF-κB signaling pathway
    Yisong Qian et al, 2018, Food Funct. CrossRef
  4. The Fungal Metabolite Eurochevalierine, a Sequiterpene Alkaloid, Displays Anti-Cancer Properties through Selective Sirtuin 1/2 Inhibition
    Michael Schnekenburger et al, 2018, Molecules CrossRef
  5. Inhibition of sirtuins 1 and 2 impairs cell survival and migration and modulates the expression of P -glycoprotein and MRP3 in hepatocellular carcinoma cell lines
    María Paula Ceballos et al, 2018, Toxicology Letters CrossRef
  6. Anticancer activities of a benzimidazole compound through sirtuin inhibition in colorectal cancer
    Yi Jer Tan et al, 2018, Future Medicinal Chemistry CrossRef
  7. Chikusetsusaponin V Inhibits LPS-Activated Inflammatory Responses via SIRT1/NF-κB Signaling Pathway in RAW264.7 Cells.
    Qin Yuan et al, 2018, Inflammation CrossRef
  8. Dichloroacetic acid (DCA) synergizes with the SIRT2 inhibitor Sirtinol and AGK2 to enhance anti-tumor efficacy in non-small cell lung cancer.
    Wenjing Ma et al, 2018, Cancer Biol Ther CrossRef
  9. Salvianolic Acid A Attenuates Endoplasmic Reticulum Stress and Protects Against Cholestasis-Induced Liver Fibrosis via the SIRT1/HSF1 Pathway
    Jie Zhu et al, 2018, Front. Pharmacol. CrossRef
  10. Recent Progress on the Discovery of Sirt2 Inhibitors for the Treatment of Various Cancers
    Ting Wang et al, 2019, CTMC CrossRef
  11. Enzymatic and Biological Characterization of Novel Sirtuin Modulators against Cancer
    Vincenzo Carafa et al, 2019, IJMS CrossRef
  12. Epigenetic Control Using Small Molecules in Cancer
    Tomohiro Kozako et al, 2020 CrossRef
  13. Biochemical mechanism and biological effects of the inhibition of silent information regulator 1 (SIRT1) by EX-527 (SEN0014196 or selisistat)
    Sylvain Broussy et al, 2020, Journal of Enzyme Inhibition and Medicinal Chemistry CrossRef
  14. Triptolide-induced apoptosis in non-small cell lung cancer via a novel miR204-5p/Caveolin-1/Akt-mediated pathway.
    Brian J Philips et al, 2020, Oncotarget CrossRef
  15. The bifunctional roles of sirtuins and their therapeutic potential in cancer
    Yeuan Ting Lee et al, 2021 CrossRef
  16. Sirtuin 2 (SIRT2): Confusing Roles in the Pathophysiology of Neurological Disorders
    Xiuqi Chen et al, 2021, Front. Neurosci. CrossRef
  17. Assessment of Pharmacological Interactions between SIRT2 Inhibitor AGK2 and Paclitaxel in Different Molecular Subtypes of Breast Cancer Cells
    Anna Wawruszak et al, 2022, Cells CrossRef
  18. HSF-1: Guardian of the Proteome Through Integration of Longevity Signals to the Proteostatic Network
    Maria I. Lazaro-Pena et al, 2022, Front. Aging CrossRef
  19. Human cytomegalovirus modulates mTORC1 to redirect mRNA translation within quiescently infected monocytes
    Michael J. Miller et al, 2024, J Virol CrossRef
  20. Investigating the Effect of EX-527 as SIRT1 Inhibitor in Breast Cancer Cell Line
    Areege Ibrahim Salih et al, 2024, Al-Rafidain J Med Sci CrossRef
  21. SIRT2 Inhibition by AGK2 Promotes Perinuclear Cytoskeletal Organisation and Reduces Invasiveness of MDA-MB-231 Triple-Negative Breast Cancer Cells in Confined In Vitro Models
    Emily Jessop et al, 2024, Cells CrossRef